Conclusion
Echocardiography has an important role for HIV patients, allowing the diagnosis of cardiac abnormalities, allowing follow-up and in evaluating the prognosis. In the HAART era, the prevalence and incidence of cardiac abnormalities should be reassessed.
The effect of HAART therapy on the incidence of HIV-related cardiovascular disease and manifestations should be prospectively determined. Prospective studies are needed to fully analyse the impact of HAART therapy on the development of cardiac abnormalities and to evaluate the potential complications due to their administration. Echocardiography with the development of new technologies such as myocardial Doppler imaging, strain-rate imaging, threedimensional and contrast echocardiography, should be useful in this respect.References
1. Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation 106:1420-5
2. Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13-22
3. Barbaro G (2003) Evolution of the involvement of the cardiovascular system in HIV infection. Adv Cardiol 40:15-22
4. Barbarini G, Barbaro G (2003) Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 17:S46-50
5. Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133:393-399
6. Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92: 3229-3234
7. Chen Y, Brennessel D, Walters J et al (1999) Immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137:516-521
8. Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement.
J Infect 40: 282-2849. Roy CL, Minor MA, Brookhart MA, Choudhry NK (2007) Does this patient with a pericardial effusion have cardiac tamponade? JAMA 297:1810-1818
10. Gowda RM, Khan IA, Sacchi TJ, Vasavada BC (2003) Cardiac tamponade in acquired immun-
odeficiency syndrome. Int J Cardiol 88:313-314
11. Iacobellis G, Pellicelli AM, Sharma AM et al (2007)Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 99:1470-1472
12. Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285-289
13. Camerini F, Bussani R, Lenarda D et al (1991) Clinical aspects and haemodynamics in the follow-up of dilated cardiomyopathy and myocarditis. Eur Heart J 12(Suppl D):193-196
14. Hiramitsu S, Morimoto S, Kato S et al (2001) Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ 65:863-866
15. Lieback E, Hardouin I, Meyer R et al (1996) Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 17:135-142
16. Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227-232
17. Mendes LA, Picard MH, Dec GW et al (1999) Ventricular remodeling in active myocarditis: myocarditis treatment trial. Am Heart J 138:303-308
18. Thuny F, Avierinos JF, Jop B et al (2006) Images in cardiovascular medicine: massive biventricular thrombosis as a consequence of myocarditis: findings from 2-dimensional and real-time 3dimensional echocardiography. Circulation 113:e932-933
19. Mendes LA, Dec GW, Picard MH et al (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301-307
20. Swedberg K, Cleland J, Dargie H et al (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26:1115-1140
21.
Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIVpositive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339:1093-109922. Cardoso JS, Moura B, Martins L et al (1998) Left ventricular dysfunction in human immunodeficiency virus (HIV) infected patients. Int J Cardiol 63:37-45
23. Longo-Mbenza B, Seghers KV, Phuati M et al (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64:63-73
24. Twagirumukiza M, Nkeramihigo E, Seminega B et al (2007) Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 5:129-137
25. Brown DL, Sather S, Cheitlin MD (1993)Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 125:1439-1441
26. Galia N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278
27. Opravil M, Pechere M, Speich R et al (1997) HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990-995
28. Mesa RA, Edell ES, Dunn WF, Edwards WD (1988) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 73:37-45
29. Petitpretz P, Brenot F, Azarian R et al (1994) Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 89:2722-2727
30. Ehrenreich H, Rieckmann P, Sinowatz F et al (1993) Potent stimulation of monocytic endothe- lin-1 production by HIV-1 glycoprotein 120.
J Immunol 150:4601-460931. Humbert M, Monti G, Fartoukh M et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11:554-559
32. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133-1141
33. Zuber JP, Calmy A, Evison JM et al; Swiss HIV Cohort Study Group (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178-1185
34. Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification. J Am Soc Echocardiogr 18:1440-1463
35. Martinez-Garcia T, Sobrino JM, Pujol E et al (2000) Ventricular mass and diastolic function in patients infected by the humanimmuno defi-
ciency virus. Heart 84:620-624
36. Coudray N, de Zuttere D, Force G et al (1995) Ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 16:61-67
37. Samaan SA, Foster A, Raizada V et al (1995) Myocardial atrophy in acquired immunodeficiency syndrome: associated wasting. Am Heart J 130:823-827
38. Meng Q, Lima JA, Lai H, Vlahov D et al (2002) HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 30:306-310
39. Losa JE, Miro JM, Del Rio A et al (2003) Endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9:45-54
40. De Rosa FG, Cicalini S, Canta F et al (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV- infected patients. Infection 35:154-160
41.
Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426-43242. Valencia E, Miro J (2004) Endocarditis in the setting of HIV infection. AIDS Rev 6:97-106
43. Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267-276
44. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962-972
45. Khan NU, Ahmed S, Wagner P et al (2004)Car- diac involvement in non-Hodgkin’s lymphoma: with and without HIV infection. Int J Cardio- vasc Imaging 20:477-481
46. Iwahashi N, Nakatani S, Kakuchi H et al (2005) Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 69:243-245